MDxHealth SA expected to post a loss of 13 cents a share - Earnings Preview

MDxHealth SA

12/05/2025 22:04

MDxHealth SA MDXH.OQ MDXH.O is expected to show a rise in quarterly revenue when it reports  results on May 14 for the period ending March 31 2025

The Herstal Liege-based  company is expected to report a 21.4% increase in revenue to $24.07 million from $19.83 million a year ago, according to the mean estimate from 6 analysts, based on LSEG data.

‚ÄčLSEG's mean analyst estimate for MDxHealth SA is for a loss of 13 cents per share.

The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 6 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ‚Äč

Wall Street's median 12-month price target for MDxHealth SA is $6.00‚Äč, above‚Äč its last closing price of $1.87. ‚Äč‚Äč‚Äč

Previous quarterly performance (using preferred earnings measure in US dollars). ‚Äč

QUARTER ENDING
STARMINESMARTESTIMATE¬ģ
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Dec. 31 2024
-0.18
-0.19
-0.14
Beat
27.1
Sep. 30 2024
-0.28
-0.27
-0.40
Missed
-48.1
Jun. 30 2024
-0.27
-0.26
-0.42
Missed
-58.5‚Äč
Mar. 31 2024
-0.31
-0.30
-0.31
Missed
-3.3
‚Äč‚ÄčDec. 31 2023
-0.22
-0.11
-0.39
Missed
-254.5
Sep. 30 2023
-0.21
-0.19
-0.40
Missed
-108.3‚Äč
Jun. 30 2023
-0.25
-0.22
-0.30
Missed
-37.6
Mar. 31 2023
-0.32
-0.32
-0.50
Missed
-55

This summary was machine generated May 12 at 21:04 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)